Abstract
Purpose of Review
The purpose of this review is to discuss the pathogenesis, clinical manifestations, and diagnosis treatment of sleep apnea at high altitude as well and acute altitude illnesses.
Recent Findings
Differences in adaptive responses of different native highlander populations are leading to interesting new insights into high-altitude physiology.
Summary
Periodic breathing at altitude is a physiologic response to hypobaric oxygen and patients with obstructive sleep apnea have transition of respiratory events from obstructive to central at altitude. Acetazolamide is first-line therapy for periodic breathing at altitude. Other acute altitude illnesses are best treated with descent to a lower altitude.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
West JB. The physiologic basis of high-altitude diseases. Ann Intern Med. 2004;141(10):789–800.
West JB, Lahiri S, Maret KH, Peters RM Jr, Pizzo CJ. Barometric pressures at extreme altitudes on Mt. Everest: physiological significance. J Appl Physiol Respir Environ Exerc Physiol. 1983;54(5):1188–94.
Widdicombe J. Airway receptors. Respir Physiol. 2001;125(1-2):3–15.
Murray, J.F., J.A. Nadel, and R.J. Mason, Murray and Nadel’s textbook of respiratory medicine. 4th ed. 2005, Philadelphia, Pa.: Elsevier Saunders. 2 volumes (xxiv, 2, 486, cxx pages, 32 unnumbered pages of plates).
Guyenet PG, Abbott SB, Stornetta RL. The respiratory chemoreception conundrum: light at the end of the tunnel? Brain Res. 2013;1511:126–37.
West JB. Respiratory physiology: the essentials. 8th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. ix; 2008. 186 pages.
Smith JC, et al. Pre-Botzinger complex: a brainstem region that may generate respiratory rhythm in mammals. Science. 1991;254(5032):726–9.
Orem J. The nature of the wakefulness stimulus for breathing. Prog Clin Biol Res. 1990;345:23–30 discussion 31.
Hackett PH, Roach RC. High-altitude illness. N Engl J Med. 2001;345(2):107–14.
Lahiri S, Barnard P. Role of arterial chemoreflex in breathing during sleep at high altitude. Prog Clin Biol Res. 1983;136:75–85.
Nakayama H, et al. Carotid body denervation eliminates apnea in response to transient hypocapnia. J Appl Physiol (1985). 2003;94(1):155–64.
White DP, et al. Altitude acclimatization: influence on periodic breathing and chemoresponsiveness during sleep. J Appl Physiol (1985). 1987;63(1):401–12.
Weil JV. Sleep at high altitude. High Alt Med Biol. 2004;5(2):180–9.
Burgess KR, Johnson PL, Edwards N. Central and obstructive sleep apnoea during ascent to high altitude. Respirology. 2004;9(2):222–9.
Dempsey JA, Skatrud JB. A sleep-induced apneic threshold and its consequences. Am Rev Respir Dis. 1986;133(6):1163–70.
Dempsey JA. Crossing the apnoeic threshold: causes and consequences. Exp Physiol. 2005;90(1):13–24.
Dempsey JA. Crossing the apnoeic threshold: causes and consequences. Exp Physiol. 2005;90(1):13–24.
Lahiri S, Maret K, Sherpa MG. Dependence of high altitude sleep apnea on ventilatory sensitivty to hypoxia. Respir Physiol. 1983;52(3):281–301.
Hackett PH, Roach RC, Harrison GL, Schoene RB, Mills WJ Jr. Respiratory stimulants and sleep periodic breathing at high altitude. Almitrine versus acetazolamide. Am Rev Respir Dis. 1987;135(4):896–8.
Sutton JR, Gray GW, Houston CS, Powles ACP. Effects of duration at altitude and acetazolamide on ventilation and oxygenation during sleep. Sleep. 1980;3(3-4):455–64.
Swenson ER, Leatham KL, Roach RC, Schoene RB, Mills WJ Jr, Hackett PH. Renal carbonic anhydrase inhibition reduces high altitude sleep periodic breathing. Respir Physiol. 1991;86(3):333–43.
Edwards BA, Sands SA, Feeney C, Skuza EM, Brodecky V, Wilkinson MH, et al. Continuous positive airway pressure reduces loop gain and resolves periodic central apneas in the lamb. Respir Physiol Neurobiol. 2009;168(3):239–49.
Bayliss DA, Millhorn DE. Central neural mechanisms of progesterone action: application to the respiratory system. J Appl Physiol (1985). 1992;73(2):393–404.
Zhou XS, et al. Effect of testosterone on the apneic threshold in women during NREM sleep. J Appl Physiol (1985). 2003;94(1):101–7.
Lombardi C, Meriggi P, Agostoni P, Faini A, Bilo G, Revera M, et al. High-altitude hypoxia and periodic breathing during sleep: gender-related differences. J Sleep Res. 2013;22(3):322–30.
Caravita S, Faini A, Lombardi C, Valentini M, Gregorini F, Rossi J, et al. Sex and acetazolamide effects on chemoreflex and periodic breathing during sleep at altitude. Chest. 2015;147(1):120–31.
Burgess KR, et al. Effect of simulated altitude during sleep on moderate-severity OSA. Respirology. 2006;11(1):62–9.
Nussbaumer-Ochsner Y, Schuepfer N, Ulrich S, Bloch KE. Exacerbation of sleep apnoea by frequent central events in patients with the obstructive sleep apnoea syndrome at altitude: a randomised trial. Thorax. 2010;65(5):429–35.
Badr MS, Skatrud JB, Dempsey JA. Determinants of poststimulus potentiation in humans during NREM sleep. J Appl Physiol (1985). 1992;73(5):1958–71.
McSharry DG, Saboisky JP, DeYoung P, Jordan AS, Trinder J, Smales E, et al. Physiological mechanisms of upper airway hypotonia during REM sleep. Sleep. 2014;37(3):561–9.
Badr MS, et al. Pharyngeal narrowing/occlusion during central sleep apnea. J Appl Physiol (1985). 1995;78(5):1806–15.
• Liu H-M, et al. The effect of acetazolamide on sleep apnea at high altitude: a systematic review and meta-analysis. Ther Adv Respir Dis. 2017;11(1):20–9 Summarizing the numerous studies that have investigated acetazolamide as a treatment for high altitude illness.
Latshang TD, Nussbaumer-Ochsner Y, Henn RM, Ulrich S, Lo Cascio CM, Ledergerber B, et al. Effect of acetazolamide and AutoCPAP therapy on breathing disturbances among patients with obstructive sleep apnea syndrome who travel to altitude. JAMA. 2012;308(22):2390–8.
Bloch KE, Latshang TD, Ulrich S. Patients with obstructive sleep apnea at altitude. High Alt Med Biol. 2015;16(2):110–6.
Bloch KE. Alternatives to CPAP in the treatment of the obstructive sleep apnea syndrome. Swiss Med Wkly. 2006;136(17-18):261–7.
Berry RB, Kryger MH, Massie CA. A novel nasal expiratory positive airway pressure (EPAP) device for the treatment of obstructive sleep apnea: a randomized controlled trial. Sleep. 2011;34(4):479–85.
Smith CA, Blain GM, Henderson KS, Dempsey JA. Peripheral chemoreceptors determine the respiratory sensitivity of central chemoreceptors to CO2: role of carotid body CO2. J Physiol. 2015;593(18):4225–43.
Fatemian M, Robbins PA. Selected contribution: chemoreflex responses to CO2 before and after an 8-h exposure to hypoxia in humans. J Appl Physiol (1985). 2001;90(4):1607–14 discussion 1606.
West JB, Wagner PD. Predicted gas exchange on the summit of Mt. Everest Respir Physiol. 1980;42(1):1–16.
Knaupp W, et al. Erythropoietin response to acute normobaric hypoxia in humans. J Appl Physiol (1985). 1992;73(3):837–40.
West JB. High-altitude medicine. Am J Respir Crit Care Med. 2012;186(12):1229–37.
• Roach RC, et al. The 2018 Lake Louise Acute Mountain Sickness Score. High Alt Med Biol. 2018;19(1):4–6 Objective evaluation of acute mountain sickness.
Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. Chest. 2006;129(1):174–81.
Luks AM, Auerbach PS, Freer L, Grissom CK, Keyes LE, McIntosh SE, et al. Wilderness medical society clinical practice guidelines for the prevention and treatment of acute altitude illness: 2019 update. Wilderness Environ Med. 2019;30(4S):S3–S18.
Tseng CH, Lin FC, Chao HS, Tsai HC, Shiao GM, Chang SC. Impact of rapid ascent to high altitude on sleep. Sleep Breath. 2015;19(3):819–26.
Eichenberger U, Weiss E, Riemann D, Oelz O, Bärtsch P. Nocturnal periodic breathing and the development of acute high altitude illness. Am J Respir Crit Care Med. 1996;154(6 Pt 1):1748–54.
Luks AM. Do lung disease patients need supplemental oxygen at high altitude? High Alt Med Biol. 2009;10(4):321–7.
Stokes S, Kalson N, Earl M, Frost H, Whitehead AG, Tyrrell-Marsh I, et al. Bronchial asthma on Mount Kilimanjaro is not a disadvantage. Thorax. 2008;63(10):936–7.
Reeves JT, et al. Operation Everest II: preservation of cardiac function at extreme altitude. J Appl Physiol (1985). 1987;63(2):531–9.
Luks AM. Can patients with pulmonary hypertension travel to high altitude? High Alt Med Biol. 2009;10(3):215–9.
Flint J, Harding RM, Boyce AJ, Clegg JB. The population genetics of the haemoglobinopathies. Baillieres Clin Haematol. 1998;11(1):1–51.
Bigham AW, Wilson MJ, Julian CG, Kiyamu M, Vargas E, Leon-Velarde F, et al. Andean and Tibetan patterns of adaptation to high altitude. Am J Hum Biol. 2013;25(2):190–7.
Beall CM, Decker MJ, Brittenham GM, Kushner I, Gebremedhin A, Strohl KP. An Ethiopian pattern of human adaptation to high-altitude hypoxia. Proc Natl Acad Sci U S A. 2002;99(26):17215–8.
• Moore LG. Measuring high-altitude adaptation. J Appl Physiol. 2017;123(5):1371–85 Investigations of various native highlander populations reveals insights into physiological mechanisms of high altitude adaptation.
Wagner PD, et al. Pulmonary gas exchange and acid-base state at 5,260 m in high-altitude Bolivians and acclimatized lowlanders. J Appl Physiol (1985). 2002;92(4):1393–400.
Brutsaert TD, Soria R, Caceres E, Spielvogel H, Haas JD. Effect of developmental and ancestral high altitude exposure on chest morphology and pulmonary function in Andean and European/North American natives. Am J Hum Biol. 1999;11(3):383–95.
Zhuang J, Droma T, Sutton JR, Groves BM, McCullough RE, McCullough RG, et al. Smaller alveolar-arterial O2 gradients in Tibetan than Han residents of Lhasa (3658 m). Respir Physiol. 1996;103(1):75–82.
Sawka MN, et al. Altitude acclimatization and blood volume: effects of exogenous erythrocyte volume expansion. J Appl Physiol (1985). 1996;81(2):636–42.
Leon-Velarde F, et al. Consensus statement on chronic and subacute high altitude diseases. High Alt Med Biol. 2005;6(2):147–57.
Villafuerte FC, Corante N. Chronic mountain sickness: clinical aspects, etiology, management, and treatment. High Alt Med Biol. 2016;17(2):61–9.
Leon-Velarde F, Richalet JP. Respiratory control in residents at high altitude: physiology and pathophysiology. High Alt Med Biol. 2006;7(2):125–37.
Kryger M, McCullough R, Doekel R, Collins D, Weil JV, Grover RF. Excessive polycythemia of high altitude: role of ventilatory drive and lung disease. Am Rev Respir Dis. 1978;118(4):659–66.
Richalet JP, Rivera M, Bouchet P, Chirinos E, Onnen I, Petitjean O, et al. Acetazolamide: a treatment for chronic mountain sickness. Am J Respir Crit Care Med. 2005;172(11):1427–33.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Conflict of Interest
Drs. Divya Venkat, Kunwardeep Dhillon, and James A. Rowley declare no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Sleeping and Breathing
Rights and permissions
About this article
Cite this article
Venkat, D., Dhillon, K. & Rowley, J.A. Effects of High Altitude on Sleep and Respiratory System. Curr Pulmonol Rep 10, 103–109 (2021). https://doi.org/10.1007/s13665-021-00276-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13665-021-00276-0